![Babatunde Otulana](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Babatunde Otulana
Direktor/Vorstandsmitglied bei
ALLERGY THERAPEUTICS PLC
Vermögen: 4 024 $ am 31.07.2026
Profil
Dr. Babatunde A. Otulana, MD, is a Chief Medical Officer at Veloxis Pharmaceuticals, Inc., a Senior Independent Non-Executive Director at Allergy Therapeutics Plc, an Associate Clinical Professor at University of California, Davis and a Member of United Nations Environment Programme.
He is on the Board of Directors at Allergy Therapeutics Plc and Flow Pharma, Inc. Dr. Otulana was previously employed as a Non-Executive Director by Revolo Biotherapeutics Ltd., a Chief Medical Officer & Senior Vice President by Mallinckrodt Plc, a Chief Medical Officer & Senior Vice President by Mallinckrodt Pharmaceuticals Ltd., a Senior VP-Clinical Development & Medical Affairs by Boehringer Ingelheim Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by Aerovance, Inc., a Chief Medical Officer & SVP-Development by Aradigm Corp., and a Medical Officer & Clinical Team Leader by Center for Drug Evaluation & Research.
He received his doctorate degree from the University of Ibadan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 50.000 ( 0 % ) | 4 024 $ | 31.07.2026 |
Aktive Positionen von Babatunde Otulana
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 06.06.2017 |
United Nations Environment Programme
 United Nations Environment Programme General GovernmentGovernment Government agency | Corporate Officer/Principal | 17.05.2010 |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 17.05.2010 |
Veloxis Pharmaceuticals, Inc.
 Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Flow Pharma, Inc.
 Flow Pharma, Inc. Internet Software/ServicesTechnology Services Operates as t-cell based vaccine delivery platform | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Babatunde Otulana
| Unternehmen | Position | Ende |
|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| MALLINCKRODT PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| ARADIGM CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2008 |
| ░░░░░░ ░░░ ░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Babatunde Otulana
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of Ibadan
 University of Ibadan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
United Nations Environment Programme
United Nations Environment Programme General GovernmentGovernment Government agency | Government |
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Health Technology |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Flow Pharma, Inc.
Flow Pharma, Inc. Internet Software/ServicesTechnology Services Operates as t-cell based vaccine delivery platform | Technology Services |
